The impact of smoking on the antiplatelet action of clopidogrel in non‐ST‐elevation myocardial infarction patients: results from the ISAR‐REACT 4 platelet substudy

Saved in:
Bibliographic Details
Published inJournal of thrombosis and haemostasis Vol. 10; no. 10; pp. 2199 - 2202
Main Authors SIBBING, D., BERNLOCHNER, I., SCHULZ, S., MASSBERG, S., SCHÖMIG, A., MEHILLI, J., KASTRATI, A.
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.10.2012
Subjects
Aged
Aged, 80 and over
Female
Germany
Humans
Male
Middle Aged
Myocardial Infarction - blood
Myocardial Infarction - drug therapy
Myocardial Infarction - therapy
Percutaneous Coronary Intervention - adverse effects
Percutaneous Coronary Intervention - instrumentation
Platelet Aggregation - drug effects
Platelet Aggregation Inhibitors - therapeutic use
Platelet Function Tests
Smoking - adverse effects
Smoking - blood
Stents
Ticlopidine - analogs & derivatives
Ticlopidine - therapeutic use
Treatment Outcome
Germany
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
ObjectType-Article-2
content type line 63
ObjectType-Correspondence-1
ObjectType-Undefined-3
ISSN:1538-7933
1538-7836
1538-7836
DOI:10.1111/j.1538-7836.2012.04867.x